BriefTea
Every story in sixty words
Get the free app no ads · no paywallExplained in plain English
What is Trontinemab?
Trontinemab is an experimental drug made by Roche, a Swiss company. It's designed to target harmful proteins in the brain, which are thought to play a key role in the development of Alzheimer's. This trial will test if it can effectively block the disease's progression in people who haven't yet shown symptoms.
Stories that explain this
NHS begins testing a new Alzheimer's drug on adults without memory problemsRelated explainers
Why test healthy adults? Can we stop Alzheimer's early? Why are troop numbers important? Where is Trondheim? Why are troops going to Milan? How do trolls disrupt politics?The full catalogue
Browse every card filed under T →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.